Skip to main content
Top
Published in: Comparative Clinical Pathology 2/2020

01-04-2020 | Lymphoma | Case Report

Rare case presentation: DLBCL and plasma cell myeloma coexisting together

Authors: Vikrant Singh Bhar, Deepa Goel, Hari Goyal, Mohit Saxena

Published in: Comparative Clinical Pathology | Issue 2/2020

Login to get access

Abstract

The synchronous presence of dual hematological malignancy is an uncommon finding. In the present case, an 82-year-old male, presented with lymph nodal mass which was diagnosed as diffuse large B cell lymphoma (DLBCL) on histopathology and plasma cell myeloma (PCM), was diagnosed with identification of clonal plasma cells in the bone marrow. Interestingly, both clonal plasma cells and lymphoma cells showed lambda light chain restriction. The patient also developed spontaneous tumor lysis syndrome which can be seen in aggressive hematopoietic malignancies. The present case is a rare presentation of synchronous dual hematological malignancies and poses diagnostic and therapeutic challenge.
Literature
go back to reference Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K (2016) Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood. 127(8):965–970CrossRef Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K (2016) Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood. 127(8):965–970CrossRef
go back to reference Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3–11CrossRef Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3–11CrossRef
go back to reference Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 103(1):275–282CrossRef Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 103(1):275–282CrossRef
go back to reference Hasskarl J, Ihorst G, De Pasquale D, Schröttner P, Zerweck A, Wäsch R, Engelhardt M (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247–259CrossRef Hasskarl J, Ihorst G, De Pasquale D, Schröttner P, Zerweck A, Wäsch R, Engelhardt M (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247–259CrossRef
go back to reference Kotchetkov R, Ellison E, McLean J, Pressnail B, Nay D (2018) Synchronous dual hematological malignancies: new or underreported entity? Hematology. 23(9):596–599CrossRef Kotchetkov R, Ellison E, McLean J, Pressnail B, Nay D (2018) Synchronous dual hematological malignancies: new or underreported entity? Hematology. 23(9):596–599CrossRef
go back to reference Larocca A, Bringhen S, Petrucci MT, Oliva S, Falcone AP, Caravita T, Villani O, Benevolo G, Liberati AM, Morabito F, Montefusco V, Passera R, de Rosa L, Omedé P, Vincelli ID, Spada S, Carella AM, Ponticelli E, Derudas D, Genuardi M, Guglielmelli T, Nozzoli C, Aghemo E, de Paoli L, Conticello C, Musolino C, Offidani M, Boccadoro M, Sonneveld P, Palumbo A (2016) A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. Leukemia. 30(6):1320–1326CrossRef Larocca A, Bringhen S, Petrucci MT, Oliva S, Falcone AP, Caravita T, Villani O, Benevolo G, Liberati AM, Morabito F, Montefusco V, Passera R, de Rosa L, Omedé P, Vincelli ID, Spada S, Carella AM, Ponticelli E, Derudas D, Genuardi M, Guglielmelli T, Nozzoli C, Aghemo E, de Paoli L, Conticello C, Musolino C, Offidani M, Boccadoro M, Sonneveld P, Palumbo A (2016) A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. Leukemia. 30(6):1320–1326CrossRef
go back to reference Mitra S, Mukherjee S, Mehta J, Bhattacharyya M, Chakraborty H (2016) Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma. Indian J Pathol Microbiol 59(3):427–428CrossRef Mitra S, Mukherjee S, Mehta J, Bhattacharyya M, Chakraborty H (2016) Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma. Indian J Pathol Microbiol 59(3):427–428CrossRef
go back to reference Rajkumar SV, Dimopoulos MA, Palumbo A, et al. (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol Rajkumar SV, Dimopoulos MA, Palumbo A, et al. (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol
go back to reference Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937–1947CrossRef Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937–1947CrossRef
go back to reference Stewart BW, Wild CP (2014) World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer Stewart BW, Wild CP (2014) World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer
go back to reference Zhou S, Ma Y, Bi L, Shen Z, Yu K (2014) Simultaneous occurrence of two B-cell malignancies: a case report. Oncol Lett 8(2):908–910CrossRef Zhou S, Ma Y, Bi L, Shen Z, Yu K (2014) Simultaneous occurrence of two B-cell malignancies: a case report. Oncol Lett 8(2):908–910CrossRef
Metadata
Title
Rare case presentation: DLBCL and plasma cell myeloma coexisting together
Authors
Vikrant Singh Bhar
Deepa Goel
Hari Goyal
Mohit Saxena
Publication date
01-04-2020
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 2/2020
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-019-03082-y

Other articles of this Issue 2/2020

Comparative Clinical Pathology 2/2020 Go to the issue